Abstract:Abstract Epidermolysis bullosa (EB) comprises a collection of rare skin fragility diseases characterized by mucocutaneous wounding from minimal trauma. For recessive dystrophic EB (RDEB), a paucity of detailed knowledge about symptom presentation, severity and progression throughout life, treatment resource use and costs poses a challenge for delivering robust clinical trials and interpreting RDEB findings. The Prospective EB Longitudinal Evaluation Study (PEBLES) was established to explore the natural history of RDEB and identify potential outcome measures for clinical trial use. This prospective longitudinal observational study was designed to collect comprehensive data from a large cohort of patients with RDEB across all ages recruited from two national UK EB reference centres. Data collection at baseline and annually (≥ 10 year olds) or 6-monthly (< 10 year olds) was wide ranging, including clinical features, laboratory parameters, events occurring in the review period (hospital admissions, squamous cell carcinoma), interventions (hand surgery, oesophageal dilatation), severity and quality of life scores, resource use and socioeconomic costs. Reviews were conducted as face-to-face interviews (virtual reviews during the COVID-19 pandemic), and health records (electronic, paper) were explored to update information since the preceding visit. Screening commenced in November 2014, with 71 UK participants recruited over 9 years (54 adult, 17 child recruits). Their subtypes were RDEB-severe (n = 28), RDEB-intermediate (n = 25), RDEB-inversa (n = 11), RDEB-pruriginosa (n = 6) and RDEB-pretibial (n = 1). They provided 427 reviews, median 7 (range 1–16), with 54 (76%) providing ongoing reviews (median 7 years’ participation); six (8%) died and 11 (15%) withdrew. The preliminary findings were reported as oral and poster conference presentations, with subsequent findings prepared for publication, including itch, wound care costs, pain, quality of life, and milestone events. A steering group monitored study conduct and advised on plans to analyse and disseminate the findings, including future use of an approved repository for findings. To ensure the sustainability of PEBLES and to facilitate expansion to new sites, a REDCap database replaced the original bespoke database. Attempts to expand PEBLES in the UK were unsuccessful, but an expansion team facilitated establishment of two new sites (Austria and Germany), with recruitment to commence early 2024. PEBLES has generated a large number of linked reviews, with publications of important findings regarding itch and costs of wound care and further dissemination planned. PEBLES can be expanded to additional sites, which will increase the participant pool and allow comparison of findings from three countries. Study findings will enable clinicians and researchers to better understand RDEB and variations across subtypes and could form a detailed synthetic control for future RDEB trials.

Epidemiology of epidermolysis bullosa in Chile

Hereditary epidermolysis bullosa: clinical-epidemiological profile of 278 patients at a tertiary hospital in São Paulo, Brazil

Economic burden and health-related quality of life in patients with epidermolysis bullosa in Spain

Advantages of whole-exome sequencing over immunomapping in 67 Brazilian patients with epidermolysis bullosa

Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed?

Epidemiological Characteristics of Inherited Epidermolysis Bullosa in an Eastern European Population

Inpatient Management of Epidermolysis Bullosa: Consensus-Based Hands-On Instructions for Neonates and Post-Neonates

Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa

[Epidemiological profile of patients with cardiovascular morbidity in an insular population in Chile: Report from the Juan Fernández Archipelago]

Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis

Epidermolysis bullosa: Advances in research and treatment

Descriptive Study of the Clinical and Molecular Features of Epidermolysis Bullosa Patients in a Romanian European Reference Network-Skin Affiliated Reference Center

Epidermolysis Bullosa—A Kindler Syndrome Case Report and Short Literature Review

SG04 (P104) Developing the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES) to explore natural history and identify endpoints for the rare disease recessive dystrophic epidermolysis bullosa

P104 Developing the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES) to explore natural history and identify endpoints for the rare disease recessive dystrophic epidermolysis bullosa

Rare Disease Focused Antenatal Education and Diagnosis Support: Two Case Studies of Epidermolysis Bullosa Simplex

The psychosocial impact of a chronic disease in Ireland: Burdens and helpful practices for a life with epidermolysis bullosa

Bloodstream Infection in Children With Epidermolysis Bullosa

Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa

Colorectal cancer trends in Chile: a Latin-American country with marked socioeconomic inequities

Inequities in Breast Cancer Outcomes in Chile: An Analysis of Case Fatality and Survival Rates (2007-2018)